Related Experiment Video
Updated: May 6, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Alternatively spliced, truncated GCSF receptor promotes leukemogenic properties and sensitivity to JAK inhibition
H M Mehta1, M Futami2, T Glaubach1
1Department of Pediatrics (Hematology-Oncology) and Cell and Molecular Biology, Lurie Children's Hospital of Chicago, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Insights
Granulocyte colony-stimulating factor receptor (GCSFR) class IV isoform is elevated in AML and promotes leukemia by enhancing proliferation and impairing differentiation, yet remains sensitive to JAK2 inhibitors.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Granulocyte colony-stimulating factor (GCSF) regulates neutrophil production via the GCSF receptor (GCSFR/CSF3R).
- Mutations in GCSFR are linked to myelodysplasia/acute myeloid leukemia (AML) in children with severe congenital neutropenia.
- Alternative splicing of CSF3R generates multiple isoforms, including class IV, whose biology is largely unknown.
Purpose of the Study:
- To investigate the biological role and signaling of the alternatively spliced class IV GCSFR isoform.
- To determine the impact of class IV GCSFR expression on cell proliferation, differentiation, and apoptosis in AML.
- To assess the sensitivity of class IV GCSFR-mediated signaling to JAK2 inhibitors.
Main Methods:
- Analysis of CSF3R isoform expression in adult myelodysplastic syndrome/AML patients.
- Investigation of developmental regulation of CSF3R isoforms.
- Phosphoprotein signaling analysis involving JAK-STAT pathways and cell cycle gene expression.
- Assessment of proliferation, differentiation, and apoptosis in response to class IV GCSFR.
Main Results:
- Class IV CSF3R expression is elevated in adult AML patients and is more representative of a progenitor cell stage.
- Enhanced proliferation driven by class IV GCSFR is associated with diminished STAT3 and STAT5 activation.
- Class IV GCSFR signaling remains sensitive to JAK2 inhibitors.
- Alterations in the GCSFR C-terminal domain confer leukemic properties, including enhanced growth and resistance to apoptosis.
Conclusions:
- The class IV GCSFR isoform may act as an oncogenic driver in AML.
- Class IV GCSFR promotes leukemic properties through enhanced proliferation and impaired differentiation.
- Targeting JAK2 may be a viable therapeutic strategy for AML patients with altered GCSFR.
Abstract:
Granulocyte colony-stimulating factor (GCSF) drives the production of myeloid progenitor and precursor cells toward neutrophils via the GCSF receptor (GCSFR, gene name CSF3R). Children with severe congenital neutropenia chronically receive pharmacologic doses of GCSF, and ∼30% will develop myelodysplasia/acute myeloid leukemia (AML) associated with GCSFR truncation mutations. In addition to mutations, multiple isoforms of CSF3R have also been reported. We found elevated expression of the alternatively spliced isoform, class IV CSF3R in adult myelodysplastic syndrome/AML patients. Aside from its association with monosomy 7 and higher rates of relapse in pediatric AML patients, little is known about the biology of the class IV isoform. We found developmental regulation of CSF3R isoforms with the class IV expression more representative of a progenitor cell stage. Striking differences were found in phosphoprotein signaling involving Janus kinase (JAK)-signal transducer and activator of transcription (STAT) and cell cycle gene expression. Enhanced proliferation by class IV GCSFR was associated with diminished STAT3 and STAT5 activation, yet showed sensitivity to JAK2 inhibitors. Alterations in the C-terminal domain of the GCSFR result in leukemic properties of enhanced growth, impaired differentiation and resistance to apoptosis, suggesting that they can behave as oncogenic drivers, sensitive to JAK2 inhibition.
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a...
GPCR Desensitization
GPCRs Regulate Adenylyl Cylase Activity

